The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double‐blind, placebo‐controlled, randomised crossover trial-Reference-Cited by-同舟云学术

The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double‐blind, placebo‐controlled, randomised crossover trial

Published:2021-07-14 Issue:17 Volume:599 Page:4183-4195
ISSN:0022-3751
Container-title:The Journal of Physiology
language:en
Short-container-title:J Physiol

Author:

Lim Richard¹²^ORCID,Messineo Ludovico³^ORCID,Grunstein Ronald R.⁴⁵,Carberry Jayne C.¹³⁶^ORCID,Eckert Danny J.¹²³^ORCID

Affiliation:

1. Neuroscience Research Australia (NeuRA) New South Wales Sydney Australia

2. School of Medical Sciences University of New South Wales New South Wales Sydney Australia

3. Flinders Health and Medical Research Institute and Adelaide Institute for Sleep Health Flinders University Bedford Park South Australia Australia

4. Woolcock Institute of Medical Research Sydney Medical School the University of Sydney New South Wales Glebe Australia

5. Department of Respiratory and Sleep Medicine Royal Prince Alfred Hospital New South Wales Camperdown Australia

6. UCD School of Medicine University College Dublin, Belfield Dublin Ireland

Publisher

Wiley

Subject

Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1113/JP281912

Reference49 articles.

1. Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity

2. Hypertension Is Associated With Undiagnosed OSA During Rapid Eye Movement Sleep

3. Rules for Scoring Respiratory Events in Sleep: Update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events

4. Locus coeruleus noradrenergic neurons and CO2 drive to breathing

5. Personalised medicine in sleep respiratory disorders: focus on obstructive sleep apnoea diagnosis and treatment

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Emerging Role of Pharmacotherapy in Obstructive Sleep Apnea;Journal of Otorhinolaryngology, Hearing and Balance Medicine;2024-09-07

2. Effect of norepinephrine reuptake inhibitors combined with antimuscarinic agents vs monotherapy for OSA: a systematic review and meta-analysis;Journal of Clinical Sleep Medicine;2024-08

3. Pharmacological interventions for the treatment of obstructive sleep apnea syndrome;Frontiers in Medicine;2024-03-01

4. The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial;American Journal of Respiratory and Critical Care Medicine;2023-12-15

5. Pharmacological management of co-morbid obstructive sleep apnoea and insomnia;Expert Opinion on Pharmacotherapy;2023-12-12